| Novel lipids and compositions for delivery of therapeutic agent |
2023-3-07 |
2023-5-09 |
|
| Rna polymerase inhibitors and methods using same |
2023-2-11 |
2023-8-17 |
|
| Compositions and methods for treating hypertriglyceridemia |
2022-11-30 |
2023-7-06 |
|
| Lipid compositions |
2022-11-11 |
2023-2-07 |
|
| Targeted compositions |
2022-11-02 |
2023-2-07 |
|
| Liver screening method |
2022-9-28 |
2022-10-27 |
|
| Main protease (m pro) inhibitors and methods using same |
2022-9-27 |
2023-4-06 |
|
| Compositions and methods for delivering messenger rna |
2022-8-31 |
2023-6-01 |
|
| Screening method for selected amino lipid-containing compositions |
2022-8-22 |
2022-9-15 |
|
| Targeted nucleic acid conjugate compositions |
2022-8-18 |
2022-10-21 |
|
| Lipid nanoparticles for formulation |
2022-8-17 |
2022-10-27 |
|
| Cationic lipids and methods of use thereof |
2022-7-27 |
2022-10-25 |
|
| Novel lipid formulations for delivery of therapeutic agents |
2022-7-25 |
2023-8-10 |
|
| Trialkyl cationic lipids and methods of use thereof |
2022-7-20 |
2022-9-26 |
|
| Synthesis of substituted tricyclic amides and analogues thereof |
2022-7-15 |
2023-1-26 |
|
| Compositions and methods for delivering messenger RNA |
2022-6-07 |
2022-7-29 |
|
| Therapeutic compositions and methods for treating Hepatitis B |
2022-6-02 |
2022-6-23 |
|
| Lipid containing formulations |
2022-5-23 |
2022-6-23 |
|
| Methods for ameliorating infusion reactions |
2022-5-20 |
2023-2-23 |
|
| Lipid compositions |
2022-4-08 |
2022-4-28 |
|
| Substituted tetracyclic carboxylic acids, analogues thereof, and methods using … |
2022-4-04 |
2022-10-13 |
|
| Substituted 1-aryl-1'-heteroaryl compounds, substituted 1,1'-biheteroaryl … |
2022-3-28 |
2023-2-01 |
|
| Targeting lipids |
2022-2-16 |
2022-3-03 |
|
| Methods of delivering oligonucleotides to immune cells |
2022-2-10 |
2022-3-03 |
|
| Improved lipid formulation |
2022-1-24 |
2022-3-01 |
|
| Targeted conjugates comprising modified sirna |
2021-11-08 |
2022-9-01 |
|
| Substituted tricyclic amides, analogues thereof, and methods using same |
2021-7-20 |
2021-11-18 |
|
| Substituted polycyclic carboxylic acids, analogues thereof, and methods using … |
2021-7-14 |
2021-8-31 |
|
| Synthesis of substituted arylmethylureas, analogues, and crystalline forms … |
2021-6-16 |
2021-12-23 |
|
| Substituted arylmethylureas and heteroarylmethylureas, analogues thereof, and … |
2021-6-10 |
2021-11-29 |
|
| Substituted (phthalazin-1-ylmethyl)ureas, substituted n-(phthalazin-1-ylmethyl) … |
2021-6-07 |
2023-4-12 |
|
| Substituted isoquinolinylmethyl amides, analogues thereof, and methods using … |
2021-6-07 |
2023-4-12 |
|
| Liposomal apparatus and manufacturing methods |
2021-5-25 |
2022-4-12 |
2022-4-12 |
| Lipid nanoparticle formulations |
2021-5-06 |
2021-6-30 |
|
| Cationic lipids containing silicon |
2021-5-05 |
2021-6-30 |
|
| Lipid formulations for nucleic acid delivery |
2021-4-12 |
2021-10-12 |
2021-10-12 |
| Screening method for selected amino-lipid-containing compositions |
2021-4-02 |
2022-3-10 |
|
| Non-liposomal systems for nucleic acid delivery |
2021-3-16 |
2021-7-08 |
|
| Substituted 1,1'-biphenyl compounds and methods using same |
2021-2-01 |
2021-8-12 |
|
| Synthetic processes and intermediates |
2020-12-18 |
2021-10-01 |
|
| Substituted bicyclic and tricyclic ureas and amides, analogues thereof, and … |
2020-12-18 |
2021-6-24 |
|
| Substituted isoindolonyl 2,2'-bipyrimidinyl compounds, analogues thereof, and … |
2020-11-12 |
2021-5-20 |
|
| Substituted cyclopropyl-2,2'-bipyrimidinyl compounds, analogues thereof, and … |
2020-7-31 |
2022-6-08 |
|
| Liver screening method |
2020-4-03 |
2020-4-30 |
|
| Substituted pyridinone-containing trycyclic compounds, and methods using same |
2020-3-30 |
2021-5-25 |
2021-5-25 |
| Therapeutic methods for treating hepatitis b |
2020-3-20 |
2021-1-16 |
|
| Delivering crispr therapeutics with lipid nanoparticles |
2020-3-16 |
2020-12-10 |
|
| SUBSTITUTED POLYCYCLIC CARBOXYLIC ACIDS, ANALOGS THEREOF AND METHODS USING THE … |
2020-1-15 |
2021-9-21 |
|
| Targeting lipids |
2020-1-06 |
2020-1-30 |
|
| Negatively charged peg-lipid conjugates |
2019-11-08 |
2020-5-14 |
|
| Lipid nanoparticle preparation |
2019-11-08 |
2022-1-17 |
|
| Bivalent targeted conjugates |
2019-11-04 |
2021-6-17 |
|
| Crystalline forms of substituted dihydroindene-4-carboxamide compounds and … |
2019-8-27 |
2020-3-05 |
|
| Substituted tetrahydrocyclopenta[c]pyrroles, substituted dihydropyrrolizines, … |
2019-7-25 |
2021-6-17 |
|
| Crystalline forms of pyridinone-containing tricyclic compounds and methods of … |
2019-6-21 |
2020-1-01 |
|
| Site-specific delivery of nucleic acids by combining targeting ligands with … |
2019-6-13 |
2019-7-04 |
|
| Substituted 2,2'-bipyrimidinyl compounds, analogues thereof, and methods using … |
2019-5-14 |
2019-11-21 |
|
| Improved amino lipids and methods for the delivery of nucleic acids |
2019-5-14 |
2019-6-06 |
|
| Methods for preparing substituted dihydroindene-4-carboxamide compounds |
2019-4-12 |
2019-11-16 |
|
| Methods for preparing substituted pyridinone-containing tricyclic compounds |
2019-4-11 |
2019-10-17 |
|
| Substituted 1,1'-biphenyl compounds, analogues thereof, and methods using same |
2019-3-29 |
2019-10-03 |
|
| Methods for delivering improved amino lipids and nucleic acids |
2019-3-27 |
2019-8-22 |
|
| Substituted 2-pyridone tricyclic compounds, analogues thereof, and methods … |
2019-3-11 |
2023-7-18 |
2023-7-18 |
| Novel antiviral agents against hbv infection |
2019-1-31 |
2019-2-28 |
|
| Methods and compositions for delivery of nucleic acids |
2019-1-29 |
2019-2-14 |
|
| Compositions for nucleic acid delivery |
2018-12-10 |
2019-1-03 |
|
| Substituted 1-hydroxy-pyridin-2(1h)-ones, and methods of making and using same |
2018-11-29 |
2019-6-06 |
|
| Substituted 2-n-hydroxy-1,3-dioxo-1,2,3,4-tetrahydronaphthyridines, and methods … |
2018-11-29 |
2019-6-06 |
|
| Methods for treating hepatitis B infections |
2018-9-11 |
2019-6-01 |
|
| Compounds, compositions, and methods for treating or preventing hepatitis b |
2018-8-28 |
2019-3-07 |
|
| Novel cyclic cationic lipids and methods of use |
2018-8-20 |
2019-4-11 |
|
| METHODS FOR INCREASING EFFICACY OF LIPID FORMULATED siRNA |
2018-7-16 |
2019-5-23 |
|
| Therapeutic compositions and methods for treating hepatitis B |
2018-6-15 |
2019-6-01 |
|
| Compositions and methods for silencing hepatitis b virus gene expression |
2018-6-15 |
2018-10-12 |
|
| Improved lipid formulation for the delivery of nucleic acids |
2018-6-05 |
2018-6-21 |
|
| Therapeutic composition and method for treating hepatitis B |
2018-5-31 |
2019-2-16 |
|
| Substituted 2,3-dihydro-1H-indene analogs and methods using same |
2018-4-24 |
2021-9-28 |
2021-9-28 |
| DIRECTED COMPOSITIONS |
2018-4-11 |
2019-8-07 |
|
| Lipid encapsulating interfering rna |
2018-3-26 |
2019-3-07 |
|
| Substituted dihydroindene-4-carboxamides and analogs thereof, and methods using … |
2018-3-21 |
2018-11-01 |
|
| DIHYDROINDEN-4-SUBSTITUTED AND ANALOG CARBOXAMIDS OF THE SAME, AND METHODS THAT … |
2018-3-21 |
2019-6-19 |
|
| Site-specific delivery of nucleic acids by combining targeting ligands with … |
2017-12-11 |
2018-8-09 |
|
| SUBSTITUTED TRICYCLIC COMPOUNDS CONTAINING PIRIDINONE AND METHODS OF USE |
2017-11-06 |
2019-2-27 |
|
| Substituted pyridinone-containing tricyclic compounds, and methods using same |
2017-11-03 |
2022-10-28 |
|
| Methods and compositions for delivery of active agents |
2017-10-19 |
2018-8-09 |
|
| Targeting Lipids |
2017-10-10 |
2019-4-04 |
|
| Substituted chromane-8-carboxamide compounds and analogues thereof, and methods … |
2017-9-13 |
2021-7-20 |
2021-7-20 |
| Anti-pd-1 antibodies, or fragments thereof, for treating hepatitis b |
2017-8-21 |
2020-7-29 |
|
| subbstituted Dihydroindene-4-Carboxamides and Analogs Thereof, and Methods … |
2017-6-16 |
2019-9-18 |
|
| Targeted nucleic acid conjugate compositions |
2017-4-11 |
2022-4-29 |
|
| Targeted nucleic acid conjugate compositions |
2017-4-11 |
2022-4-29 |
|
| Vitro release assay for liposome encapsulated vincristine |
2017-3-24 |
2018-2-08 |
|
| Treating hepatitis b virus infection using crispr |
2016-6-06 |
2018-8-30 |
|
| Composition and method for silently expressing hepatitis B virus gene |
2015-10-02 |
2019-1-01 |
|
| Improved method for the preparation of liposome encapsulated vincristine for … |
2015-4-30 |
2019-5-30 |
|
| Inhibitors of secretion of hepatitis B virus antigens |
2014-11-21 |
2017-1-03 |
2017-1-03 |
| Ácidos carboxílicos policíclicos substituídos, análogos dos mesmos e métodos … |
2020-1-15 |
2021-9-21 |
|